BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

Commsec Interview with CEO

  1. windshift
    1,032 Posts.
    lightbulb Created with Sketch. 145
    clock Created with Sketch.
    06/05/16
    12:51
    Post #: 17695260
    Tom Piotrowski speaks with Bionomics Ltd (BNO) CEO & MD, Dr Deborah Rathjen about the company’s newly signed deals with Merck, its new anxiety drug trial and its cancer treatment trials



    The more I hear, the more I like it.
    BNO Price at posting: 34.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Drilling to commence at FAU’s Gimlet high-grade gold project following approvals
right-arrow Created with Sketch.
NEWS The 4 sectors poised to benefit from Australia's immigration wave
right-arrow Created with Sketch.
NEWS How to handle a financial crisis and turn setbacks into setups
right-arrow Created with Sketch.
NEWS View the latest ASX market news here
right-arrow Created with Sketch.
LM1 High-grade targets in focus as drilling begins at Evanston
right-arrow Created with Sketch.
NEWS New channel sampling confirms further copper at Graceland, Namibia
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.